Mandarin Oriental, Inc. v. HDI Global Insurance Company

District Court, S.D. New York·Decided September 19, 2024·No. 1:23-cv-04951·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ---------------------------------------------------------------------- X : MANDARIN ORIENTAL, INC., : : Plaintiff, : : -v- : 23 Civ. 4951 (JPC) : HDI GLOBAL INSURANCE COMPANY and : OPINION AND ORDER ASSICURAZIONI GENERALI S.P.A., : : Defendants. : : ---------------------------------------------------------------------- X

JOHN P. CRONAN, United States District Judge: This case concerns a COVID-19-related insurance dispute between Plaintiff Mandarin Oriental, Inc. (“Mandarin”) and two of its insurers, Defendants HDI Global Insurance Company (“HDI”) and Assicurazioni Generali S.p.A. (“Generali”; with HDI, “Defendants”). Mandarin brings this action seeking damages and declaratory relief, alleging that Defendants failed to honor their insurance policies’ “special perils” provisions by not paying their coverage obligation for business interruption losses Mandarin sustained in consequence of COVID-19 manifestations in persons within a five-mile radius of four of its hotels in the United States. HDI and Generali have moved to dismiss Mandarin’s Complaint pursuant to Federal Rule of Civil Procedure 12(b)(6). For reasons that follow, the Court denies Defendants’ motion to dismiss Mandarin’s breach of contract claim in Count II. The Court also declines to exercise discretionary jurisdiction over Mandarin’s declaratory judgment claim in Count I as it is duplicative of Mandarin’s breach of contract claim. The Court thus sua sponte dismisses Count I. I. Background1 A. Facts Mandarin is the holding company for the United States interests of the Mandarin Oriental Hotel Group, an international hotel investment and management group. Compl. ¶ 2. At issue in

this dispute are Mandarin’s hotels in Miami, Florida; New York, New York; Washington, D.C.; and Boston, Massachusetts. Id. Mandarin purchased “all risks” commercial lines insurance policies from a group of insurers that included HDI and Generali, under which the insurers had quota share percentages of coverage. Id. ¶¶ 8-9. Pursuant to this quota share arrangement, HDI was responsible for 25% of coverage, Generali was responsible for 10% of coverage, and the remainder of coverage fell to other non-party insurance companies. Id. ¶ 9. Mandarin’s “all risks” policies from HDI and Generali protected “against the risk of loss and damages to Mandarin’s business locations and operations.” Id. ¶¶ 10, 13. Coverage under the HDI policy began on May 1, 2018, and was extended through May 1, 2020; the Generali policy’s coverage began on May 1, 2016, and was extended through May 1, 2021. Id. ¶¶ 10-11, 13-14.

Both policies contained Endorsement No. 3, which provided coverage for certain special perils. Id. ¶ 16. Although the policies at issue have not yet been provided to the Court, various provisions of Endorsement No. 3 are quoted in the Complaint. As relevant here, Endorsement No. 3 provides that “this policy is extended to cover loss resulting from interruption of or interference with the business carried on by the Insured in consequence of: (a) Infectious or contagious disease manifested by any person while on the premises of the Insured or within a radius of 5 miles

1 The following facts, which are assumed true for purposes of this Opinion and Order, are taken from the Corrected Complaint, Dkt. 26 (“Compl.”). See Interpharm, Inc. v. Wells Fargo Bank, Nat’l Ass’n, 655 F.3d 136, 141 (2d Cir. 2011) (explaining that on a motion to dismiss pursuant to Rule 12(b)(6), the court must “assum[e] all facts alleged within the four corners of the complaint to be true, and draw[] all reasonable inferences in plaintiff’s favor”). thereof.” Id. ¶ 16. Endorsement No. 3 also states that “the length of time for which loss may be claimed shall not exceed such length of time as would be required with the exercise of due diligence and dispatch to restore the Insured’s business to the condition that would have existed had no loss occurred and shall include the time required to make the premises conform to the order

of a competent public authority, subject to any Period of Recovery stipulated in the policy and beginning with the interruption or interference with the business.” Id. ¶ 17. Endorsement No. 3 has a $10 million per occurrence sublimit, which Mandarin contends “separately applies at each of Mandarin’s four separate hotel premises.” Id. ¶¶ 18-19. Mandarin’s policies with the non-party insurers contained the same endorsement, but those policies “expressly stated that coverage under the $10 million . . . sublimit would be calculated ‘in the aggregate,’” and thus limited recovery to a “maximum loss liability of [the insurers’] quota share percentage of coverage, regardless of how many occurrences were alleged by Mandarin.” Id. ¶¶ 20-21. As alleged, Mandarin’s Miami, New York, Washington, and Boston hotels “were impacted by the COVID-19 pandemic and the attendant manifestations of COVID-19 by any person within

a 5-mile radius of each of those hotels.” Id. ¶ 25. The first COVID-19 manifestation in someone within a five-mile radius of those hotels occurred between February and March 2020, depending on the hotel. Id. ¶¶ 26-29. Mandarin suffered tens of millions of dollars in business interruption and interference losses at these locations through September 2020, and it continued to suffer such losses as of the date of the Corrected Complaint, October 26, 2023. Id. ¶¶ 30-34. Mandarin first notified Defendants of its COVID-19-related claims by email on March 24, 2020, identifying the date of loss for each hotel location. Id. ¶ 36. Although the parties corresponded through the end of 2020 regarding the claims, as alleged, neither HDI nor Generali provided Mandarin with a written coverage position letter in the normal course of handling Mandarin’s claim. Id. ¶ 37. “Through September 2020, Mandarin’s claim for its infectious disease business interruption/interference losses, including extra expense, resulting from COVID-19 totaled $69,902,437.” Id. ¶ 38. To date, HDI and Generali have made no payments to Mandarin in connection with its COVID-19-related claims. Id. ¶ 35.

B. Procedural History On June 13, 2023, Mandarin filed its Complaint in this Court against HDI and Generali, asserting two Counts. Dkt. 1. Mandarin then filed a Corrected Complaint, without objection from Defendants, on October 26, 2023. Dkt. 26. In Count I, Mandarin seeks a declaratory judgment that “pursuant to the Policies, HDI and Generali are obligated to compensate Mandarin for the entirety of its business interruption/interference losses resulting from the infectious COVID-19 disease manifested by any person within a 5-mile radius of Mandarin’s four separate hotel premises.” Compl. ¶ 55. In Count II, Mandarin asserts a breach of contract claim, alleging that HDI and Generali have breached their obligations under the policies by refusing to pay Mandarin’s claims in full. Id. ¶ 60. As part of its breach of contract claim, Mandarin also alleges that HDI

Free access — add to your briefcase to read the full text and ask questions with AI

Mandarin Oriental, Inc. v. HDI Global Insurance Company, (S.D.N.Y. 2024).

Mandarin Oriental, Inc. v. HDI Global Insurance Company (Mandarin Oriental, Inc. v. HDI Global Insurance Company) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Public Serv. Comm'n of Utah v. Wycoff Co.
344 U.S. 237 (Supreme Court, 1952)
Wilton v. Seven Falls Co.
515 U.S. 277 (Supreme Court, 1995)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Morgan Stanley Group v. New England Ins. Co.
225 F.3d 270 (Second Circuit, 2000)
Cruz v. FXDirectDealer, LLC
720 F.3d 115 (Second Circuit, 2013)
Bi-Economy Market, Inc. v. Harleysville Insurance
886 N.E.2d 127 (New York Court of Appeals, 2008)
Maniolos v. United States
741 F. Supp. 2d 555 (S.D. New York, 2010)
Dean v. Tower Insurance
979 N.E.2d 1143 (New York Court of Appeals, 2012)
Casey v. Odwalla, Inc.
338 F. Supp. 3d 284 (S.D. Illinois, 2018)
Endemann v. Liberty Ins. Corp.
390 F. Supp. 3d 362 (N.D. New York, 2019)
Chau v. Lewis
771 F.3d 118 (Second Circuit, 2014)
Porrazzo v. Bumble Bee Foods, LLC
822 F. Supp. 2d 406 (S.D. New York, 2011)
Dorset Industries, Inc. v. Unified Grocers, Inc.
893 F. Supp. 2d 395 (E.D. New York, 2012)
Miller v. Wells Fargo Bank, N.A.
994 F. Supp. 2d 542 (S.D. New York, 2014)